Medtronic PLC
NYSE:MDT
Medtronic PLC
NYSE:MDT
Price:
87.11
USD
-0.64%
Market Cap:
$111.8B
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
Medtronic PLC
NYSE:MDT
|
IE |
|
Beijing Sinnet Technology Co Ltd
SZSE:300383
|
CN |
|
Antarctica Ltd
NSE:ANTGRAPHIC
|
IN |
|
Better Collective A/S
STO:BETCO
|
DK |
|
Brains Technology Inc
TSE:4075
|
JP |
|
J
|
Jost Werke SE
SWB:JST
|
DE |
|
Kaleido Biosciences Inc
OTC:KLDO
|
US |
|
LENSAR Inc
NASDAQ:LNSR
|
US |
|
Atomo Diagnostics Ltd
ASX:AT1
|
AU |
|
Marg Techno-Projects Ltd
BSE:540254
|
IN |
|
C
|
Componenta Oyj
OMXH:CTH1V
|
FI |
|
Shenzhen Ridge Engineering Consulting Co Ltd
SZSE:300977
|
CN |
|
Newtek Business Services Corp
NASDAQ:NEWT
|
US |
|
Cogna Educacao SA
BOVESPA:COGN3
|
BR |
|
Definity Financial Corp
F:XR6
|
CA |
|
K-Fast Holding AB
STO:KFAST B
|
SE |
|
J
|
Jiangsu Boamax Technologies Group Co Ltd
SZSE:002514
|
CN |
|
Tempest Minerals Ltd
ASX:TEM
|
AU |
|
L
|
Langold Real Estate Co Ltd
SZSE:002305
|
CN |
Multiples-Based Value
The Multiples-Based Value of one
MDT
stock under the Base Case scenario is
hidden
USD.
Compared to the current market price of 87.11 USD,
Medtronic PLC
is
hidden
.
Multiples-Based Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Relative Valuation FAQ:
MDT Multiples-Based Value
LOCKED
Multiples Across Competitors
MDT Competitors Multiples
Medtronic PLC Competitors
Medtronic PLC Competitors
All Countries
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| IE |
|
Medtronic PLC
NYSE:MDT
|
111.6B USD | 3.2 | 24.2 | 13.4 | 19.5 | |
| US |
|
Abbott Laboratories
NYSE:ABT
|
181.6B USD | 4.1 | 27.7 | 15.9 | 21.8 | |
| US |
|
Intuitive Surgical Inc
NASDAQ:ISRG
|
166.4B USD | 16 | 56.3 | 42.6 | 52.4 | |
| US |
|
Stryker Corp
NYSE:SYK
|
127.3B USD | 5 | 38.6 | 19.8 | 23.9 | |
| US |
|
Boston Scientific Corp
NYSE:BSX
|
104.1B USD | 5.1 | 35.4 | 20.8 | 28 | |
| US |
|
Edwards Lifesciences Corp
NYSE:EW
|
47.7B USD | 7.6 | 43.2 | 23.7 | 25.9 | |
| DE |
|
Siemens Healthineers AG
XETRA:SHL
|
41B EUR | 1.7 | 19.1 | 10.8 | 15.2 | |
| US |
|
IDEXX Laboratories Inc
NASDAQ:IDXX
|
45.7B USD | 10.3 | 42 | 29.8 | 32.9 | |
| US |
|
Becton Dickinson and Co
NYSE:BDX
|
44.8B USD | 2 | 25.1 | 9.9 | 16.8 | |
| US |
|
GE Healthcare Technologies Inc
NASDAQ:GEHC
|
32.6B USD | 1.5 | 15.2 | 11 | 13.3 | |
| US |
|
Resmed Inc
NYSE:RMD
|
32.4B USD | 5.9 | 21.6 | 15.1 | 16.8 |
P/S Multiple
P/E Multiple
EV/EBITDA Multiple
EV/EBIT Multiple
